MA33452B1 - Préparation de (r)- et (s)-n-(3,4-difluoro-2-(2-fluoro-4-iodophénylamino)-6-méthoxyphényl)-1- (2,3-dihydroxypropyl)cyclopropane-1-sulfonamide et de leurs dérivés protégés - Google Patents

Préparation de (r)- et (s)-n-(3,4-difluoro-2-(2-fluoro-4-iodophénylamino)-6-méthoxyphényl)-1- (2,3-dihydroxypropyl)cyclopropane-1-sulfonamide et de leurs dérivés protégés

Info

Publication number
MA33452B1
MA33452B1 MA34562A MA34562A MA33452B1 MA 33452 B1 MA33452 B1 MA 33452B1 MA 34562 A MA34562 A MA 34562A MA 34562 A MA34562 A MA 34562A MA 33452 B1 MA33452 B1 MA 33452B1
Authority
MA
Morocco
Prior art keywords
iodophenylamino
dihydroxypropyl
cyclopropane
sulfonamide
difluoro
Prior art date
Application number
MA34562A
Other languages
Arabic (ar)
English (en)
Inventor
Andreas Maderna
Jean-Michel Vernier
Original Assignee
Ardea Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42830488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33452(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardea Biosciences Inc filed Critical Ardea Biosciences Inc
Publication of MA33452B1 publication Critical patent/MA33452B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/80—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA PRÉSENTE INVENTION CONCERNE LA PRÉPARATION DE (R)-N-(3,4-DIFLUORO-2-(2- FLUORO-4-IODOPHÉNYLAMINO)-6-MÉTHOXYPHÉNYL)-1-(2,3-DIHYDROXYPROPYL)- CYCLOPROPANE-1-SULFONAMIDE ET DE (S)-N-(3,4-DIFLUORO-2-(2-FLUORO-4- IODOPHÉNYLAMINO)-6-MÉTHOXYPHÉNYL)-1-(2,3-DIHYDROXYPROPYL)CYCLOPROPANE-1-SULFONAMIDE. (I)
MA34562A 2009-07-24 2010-07-10 Préparation de (r)- et (s)-n-(3,4-difluoro-2-(2-fluoro-4-iodophénylamino)-6-méthoxyphényl)-1- (2,3-dihydroxypropyl)cyclopropane-1-sulfonamide et de leurs dérivés protégés MA33452B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22850109P 2009-07-24 2009-07-24
US22850909P 2009-07-24 2009-07-24
PCT/EP2010/004222 WO2011009541A1 (fr) 2009-07-24 2010-07-10 Préparation de (r)- et (s)-n-(3,4-difluoro-2-(2-fluoro—4-iodophénylamino)-6-méthoxyphényl)-1- (2,3-dihydroxypropyl)cyclopropane-1-sulfonamide et de leurs dérivés protégés

Publications (1)

Publication Number Publication Date
MA33452B1 true MA33452B1 (fr) 2012-07-03

Family

ID=42830488

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34562A MA33452B1 (fr) 2009-07-24 2010-07-10 Préparation de (r)- et (s)-n-(3,4-difluoro-2-(2-fluoro-4-iodophénylamino)-6-méthoxyphényl)-1- (2,3-dihydroxypropyl)cyclopropane-1-sulfonamide et de leurs dérivés protégés

Country Status (31)

Country Link
US (3) US8513443B2 (fr)
EP (1) EP2462111B1 (fr)
JP (1) JP5776115B2 (fr)
KR (1) KR101763437B1 (fr)
CN (2) CN102471246B (fr)
AR (1) AR079183A1 (fr)
AU (1) AU2010275780B2 (fr)
BR (1) BR112012001592A2 (fr)
CA (2) CA2990097A1 (fr)
CL (1) CL2012000192A1 (fr)
CO (1) CO6491075A2 (fr)
CR (1) CR20120044A (fr)
CU (1) CU24113B1 (fr)
DO (1) DOP2012000017A (fr)
EA (1) EA023623B1 (fr)
EC (1) ECSP12011621A (fr)
GT (1) GT201200017A (fr)
HN (1) HN2012000142A (fr)
IL (1) IL217312A (fr)
IN (1) IN2012DN00696A (fr)
MA (1) MA33452B1 (fr)
MX (2) MX2012001063A (fr)
MY (1) MY160421A (fr)
NZ (1) NZ597738A (fr)
PE (1) PE20120573A1 (fr)
PH (1) PH12014500158B1 (fr)
SG (1) SG177535A1 (fr)
TN (1) TN2012000027A1 (fr)
TW (1) TWI524890B (fr)
UY (1) UY32800A (fr)
WO (1) WO2011009541A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI524890B (zh) 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備
AU2012264884B2 (en) * 2011-05-27 2017-03-09 Bayer Intellectual Property Gmbh Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonamides
CN104011039A (zh) * 2011-12-19 2014-08-27 住友化学株式会社 磺酸盐的制造方法
EP2848246A1 (fr) 2013-09-13 2015-03-18 Bayer Pharma Aktiengesellschaft Compositions pharmaceutiques contenant du refametinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1912636T1 (sl) * 2005-07-21 2014-08-29 Ardea Biosciences, Inc. N-(arilamino)-sulfonamidni inhibitorji MEK
US8101799B2 (en) * 2005-07-21 2012-01-24 Ardea Biosciences Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
US7842836B2 (en) 2006-04-11 2010-11-30 Ardea Biosciences N-aryl-N'alkyl sulfamides as MEK inhibitors
JP5269762B2 (ja) * 2006-04-18 2013-08-21 アーディア・バイオサイエンシーズ・インコーポレイテッド Ｍｅｋ阻害剤としてのピリドンスルホンアミドおよびピリドンスルファミド
CA2924436A1 (fr) * 2007-07-30 2009-02-05 Ardea Biosciences, Inc. Combinaisons pharmaceutiques de n-3(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide comme inhibiteurs de mek et methodes d'utilisation
MX2010011314A (es) * 2008-04-14 2010-11-12 Ardea Biosciences Inc Composiciones y metodos de preparacion y uso de las mismas.
TWI524890B (zh) * 2009-07-24 2016-03-11 亞德生化公司 （ｒ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺及（ｓ）－ｎ－（３，４－二氟－２－（２－氟－４－碘苯胺基）－６－甲氧基苯基）－１－（２，３－二羥丙基）環丙烷－１－磺醯胺之製備

Also Published As

Publication number Publication date
CA2768788A1 (fr) 2011-01-27
ECSP12011621A (es) 2012-02-29
KR20120032536A (ko) 2012-04-05
CL2012000192A1 (es) 2012-10-05
CN102471246A (zh) 2012-05-23
AU2010275780A1 (en) 2012-02-02
US20130261320A1 (en) 2013-10-03
WO2011009541A1 (fr) 2011-01-27
TWI524890B (zh) 2016-03-11
US20120178946A1 (en) 2012-07-12
MX344965B (es) 2017-01-12
TN2012000027A1 (en) 2013-09-19
EA201200175A1 (ru) 2012-12-28
TW201113017A (en) 2011-04-16
NZ597738A (en) 2014-03-28
DOP2012000017A (es) 2012-05-15
MX2012001063A (es) 2012-03-26
BR112012001592A2 (pt) 2016-03-08
JP2013500242A (ja) 2013-01-07
CU24113B1 (es) 2015-08-27
KR101763437B1 (ko) 2017-07-31
EP2462111A1 (fr) 2012-06-13
AU2010275780B2 (en) 2015-10-22
HK1171218A1 (en) 2013-03-22
PE20120573A1 (es) 2012-05-17
EP2462111B1 (fr) 2016-03-30
CN103848808B (zh) 2016-02-10
CA2990097A1 (fr) 2011-01-27
MY160421A (en) 2017-03-15
PH12014500158A1 (en) 2015-09-07
IL217312A (en) 2017-02-28
US8884058B2 (en) 2014-11-11
CN103848808A (zh) 2014-06-11
CR20120044A (es) 2012-03-12
IN2012DN00696A (fr) 2015-06-19
HK1198364A1 (zh) 2015-04-10
SG177535A1 (en) 2012-03-29
US20150274651A1 (en) 2015-10-01
US9296686B2 (en) 2016-03-29
CN102471246B (zh) 2015-08-26
US8513443B2 (en) 2013-08-20
CO6491075A2 (es) 2012-07-31
AR079183A1 (es) 2012-01-04
JP5776115B2 (ja) 2015-09-09
GT201200017A (es) 2013-12-19
IL217312A0 (en) 2012-02-29
HN2012000142A (es) 2015-06-08
PH12014500158B1 (en) 2015-09-07
CA2768788C (fr) 2018-01-09
EA023623B1 (ru) 2016-06-30
CU20120014A7 (es) 2012-06-21
UY32800A (es) 2011-01-31

Similar Documents

Publication Publication Date Title
UA97834C2 (ru) Производные сульфониламида для лечения анормального роста клеток
MA51204B1 (fr) Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique
MY151986A (en) Adamantyl diamide derivatives and uses of same
IN2012DN00869A (fr)
CY1117681T1 (el) Ρυθμιστες 2,3-διοξυγενασης ινδολοαμινης και μεθοδοι χρησης αυτων
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
NO20081554L (no) Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav
MA33492B1 (fr) Inhibiteurs de bace
EA201070988A1 (ru) Противовирусные терапевтические средства
EA201490922A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
EA201170227A1 (ru) Имидазолкарбоксамиды
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
GT200700096A (es) Compuestos de pirazolina
BRPI0414864A (pt) composição farmacêutica multiparticulada compreendendo ácido micofenólico ou micofenolato de sódio e combinação com rapamicida
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
WO2008073332A3 (fr) Compositions de créatine pour traitement cutané
MX372721B (es) Ánalogos halogenados de agentes antifi-broticos.
EA201290229A1 (ru) Производные спиролактама и их применение
BRPI0516981A (pt) inibidores de mif
MA33452B1 (fr) Préparation de (r)- et (s)-n-(3,4-difluoro-2-(2-fluoro-4-iodophénylamino)-6-méthoxyphényl)-1- (2,3-dihydroxypropyl)cyclopropane-1-sulfonamide et de leurs dérivés protégés
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
TR201818771T4 (tr) Bilişsel Bozuklukların Tedavisinde Kullanıma Yönelik Bileşikler
MA34709B1 (fr) Compositions pharmaceutiques
EA201270512A1 (ru) Сульфонамиды для профилактики диабета
WO2011161255A3 (fr) Nouveau procédé pour la préparation de dérivés d'aminotétralines substitués sur l'azote